Market Research Logo

Global Epilepsy Drugs Market 2018-2022

Global Epilepsy Drugs Market 2018-2022

About Epilepsy Drugs

Epilepsy is a neurological disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction or psychic dysfunction.

Technavio’s analysts forecast the Global Epilepsy Drugs Market to grow at a CAGR of 7.19% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the epilepsy drugs market. To calculate the market size, the report considers the revenue generated by sales of epilepsy drugs across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, epilepsy drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Eisai
  • GlaxoSmithKline
  • Novartis
  • Pfizer
Market driver
  • Advances in understanding of epilepsy pathology
  • For a full, detailed list, view our report
Market challenge
  • Low safety profile of AEDs
  • For a full, detailed list, view our report
Market trend
  • Increasing costs of epilepsy management
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global CNS disorders therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Unmet needs of available AEDs
      • Table Need, demand, and supply analysis of AEDs
    • Pipeline drugs for epilepsy
      • Table Pipeline drugs under phase III development
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
  • Market sizing 2017
    • Market definition
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global epilepsy drugs market – Market size and forecast 2017-2022 ($ bn)
      • Table Global epilepsy drugs market – Year over year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by drug activity spectrum
    • Segmentation by drug activity spectrum
      • Table Global epilepsy drugs market by drug activity spectrum – Market share 2017-2022 (%)
    • Comparison by drug activity spectrum
      • Table Comparison by drug activity spectrum
    • Narrow spectrum drugs – Market size and forecast 2017-2022
      • Table Global epilepsy drugs market by narrow spectrum drugs – Market size and forecast 2017-2022 ($ bn)
      • Table Global epilepsy drugs market by narrow spectrum drugs – Year over year growth 2018- 2022 (%)
    • Broad spectrum drugs – Market size and forecast 2017-2022
      • Table Global epilepsy drugs market by broad spectrum drugs – Market size and forecast 2017- 2022 ($ bn)
      • Table Global epilepsy drugs market by broad spectrum drugs – Year over year growth 2018- 2022 (%)
    • Market opportunity by drug activity spectrum
      • Table Market opportunity by drug activity spectrum
  • Market segmentation by etiology
    • Segmentation by etiology
  • Market segmentation by age of onset
    • Segmentation by age of onset
  • Customer Landscape
    • Table Customer Landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global epilepsy drugs market by region – Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Epilepsy drugs market in Americas – Market size and forecast 2017-2022 ($ bn)
      • Table Epilepsy drugs market in Americas – Year over year growth 2018-2022 (%)
      • Table Top three countries in Americas
    • EMEA – Market size and forecast 2017-2022
      • Table Epilepsy drugs market in EMEA – Market size and forecast 2017-2022 ($ bn)
      • Table Epilepsy drugs market in EMEA – Year over year growth 2018-2022 (%)
      • Table Top three countries in EMEA
    • APAC – Market size and forecast 2017-2022
      • Table Epilepsy drugs market in APAC – Market size and forecast 2017-2022 ($ bn)
      • Table Epilepsy drugs market in APAC – Year over year growth 2018-2022 (%)
      • Table Top three countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Examples of epilepsy drugs discontinued due to safety issues:
  • Market trends
    • Increase in epilepsy management costs
      • Table Epilepsy management costs
      • Table Price of leading branded AEDs
    • Use of immunotherapy and immunomodulators
    • Use of genetics as therapeutics and diagnostic modality
    • Research in precision healthcare infrastructure
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Eisai
      • Table Eisai overview
      • Table Eisai – Business segments
      • Table Eisai – Organizational developments
      • Table Eisai – Geographic focus
      • Table Eisai – Segment focus
      • Table Eisai – Key offerings
    • GlaxoSmithKline
      • Table GlaxoSmithKline overview
      • Table GlaxoSmithKline – Business segments
      • Table GlaxoSmithKline – Organizational developments
      • Table GlaxoSmithKline – Geographic focus
      • Table GlaxoSmithKline – Segment focus
      • Table GlaxoSmithKline – Key offerings
    • Novartis
      • Table Novartis overview
      • Table Novartis – Business segments
      • Table Novartis – Organizational developments
      • Table Novartis – Geographic focus
      • Table Novartis – Segment focus
      • Table Novartis – Key offerings
    • Pfizer
      • Table Pfizer overview
      • Table Pfizer – Business segments
      • Table Pfizer – Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer – Segment focus
      • Table Pfizer – Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report